Crescita Therapeutics (TSX:CTX) Accounts Payable & Accrued Expense : C$4.63 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Accounts Payable & Accrued Expense?

Crescita Therapeutics's quarterly accounts payable & accrued expense declined from Sep. 2023 (C$4.76 Mil) to Dec. 2023 (C$4.33 Mil) but then increased from Dec. 2023 (C$4.33 Mil) to Mar. 2024 (C$4.63 Mil).

Crescita Therapeutics's annual accounts payable & accrued expense increased from Dec. 2021 (C$5.33 Mil) to Dec. 2022 (C$5.60 Mil) but then declined from Dec. 2022 (C$5.60 Mil) to Dec. 2023 (C$4.33 Mil).

Crescita Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Crescita Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Accounts Payable & Accrued Expense Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.94

4.27

5.33

5.60

4.33

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5.30	4.34	4.76	4.33	4.63

Crescita Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines